Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase

Ku Aida Tuansulong, Nongporn Hutadilok-Towatana, Wilawan Mahabusarakam, Decha Pinkaew, Kenichi Fujise

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Morelloflavone, a biflavonoid from Garcinia dulcis previously shown to have hypocholesterolemic activity, was examined for its effect on HMG-CoA reductase, the rate-limiting enzyme of the cholesterol biosynthetic pathway. By using the catalytic domain of house mouse HMG-CoA reductase, morelloflavone was found to inhibit the enzyme activity by competing with HMG-CoA whereas it was non-competitive towards NADPH. The inhibition constants (Ki) with respect to HMG-CoA and NADPH were 80.87 ± 0.06 μM and 103 ± 0.07 μM, respectively. Both flavonoid subunits of this compound, naringenin and luteolin, equally competed with HMGCoA with Ki of 83.58 ± 4.37 mM and 83.59 ± 0.94 μM, respectively, and were also non-competitive with NADPH (Ki of 182 ± 0.67 μM and 188 ± 0.14 μM, respectively). Due to these findings, we suggest that each subunit of morelloflavone would occupy the active site of the enzyme, thereby blocking access of its substrate. The present study thus demonstrates the ability of morelloflavone from G. dulcis to inhibit HMG-CoA reductase in vitro. As a result, this biflavonoid might serve as a new candidate for the future development of hypocholesterolemic agents.

Original languageEnglish (US)
Pages (from-to)424-428
Number of pages5
JournalPhytotherapy Research
Volume25
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Biflavonoids
Garcinia
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hydroxymethylglutaryl CoA Reductases
NADP
Catalytic Domain
Enzymes
Luteolin
Biosynthetic Pathways
Flavonoids
Cholesterol
morelloflavone

Keywords

  • Biflavonoid
  • Cholesterol biosynthesis
  • Garcinia dulcis
  • HMG-CoA reductase inhibitor
  • Morelloflavone

ASJC Scopus subject areas

  • Pharmacology

Cite this

Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase. / Tuansulong, Ku Aida; Hutadilok-Towatana, Nongporn; Mahabusarakam, Wilawan; Pinkaew, Decha; Fujise, Kenichi.

In: Phytotherapy Research, Vol. 25, No. 3, 03.2011, p. 424-428.

Research output: Contribution to journalArticle

Tuansulong, Ku Aida ; Hutadilok-Towatana, Nongporn ; Mahabusarakam, Wilawan ; Pinkaew, Decha ; Fujise, Kenichi. / Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase. In: Phytotherapy Research. 2011 ; Vol. 25, No. 3. pp. 424-428.
@article{5e2c14a19ae6423280a180e73ee834d4,
title = "Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase",
abstract = "Morelloflavone, a biflavonoid from Garcinia dulcis previously shown to have hypocholesterolemic activity, was examined for its effect on HMG-CoA reductase, the rate-limiting enzyme of the cholesterol biosynthetic pathway. By using the catalytic domain of house mouse HMG-CoA reductase, morelloflavone was found to inhibit the enzyme activity by competing with HMG-CoA whereas it was non-competitive towards NADPH. The inhibition constants (Ki) with respect to HMG-CoA and NADPH were 80.87 ± 0.06 μM and 103 ± 0.07 μM, respectively. Both flavonoid subunits of this compound, naringenin and luteolin, equally competed with HMGCoA with Ki of 83.58 ± 4.37 mM and 83.59 ± 0.94 μM, respectively, and were also non-competitive with NADPH (Ki of 182 ± 0.67 μM and 188 ± 0.14 μM, respectively). Due to these findings, we suggest that each subunit of morelloflavone would occupy the active site of the enzyme, thereby blocking access of its substrate. The present study thus demonstrates the ability of morelloflavone from G. dulcis to inhibit HMG-CoA reductase in vitro. As a result, this biflavonoid might serve as a new candidate for the future development of hypocholesterolemic agents.",
keywords = "Biflavonoid, Cholesterol biosynthesis, Garcinia dulcis, HMG-CoA reductase inhibitor, Morelloflavone",
author = "Tuansulong, {Ku Aida} and Nongporn Hutadilok-Towatana and Wilawan Mahabusarakam and Decha Pinkaew and Kenichi Fujise",
year = "2011",
month = "3",
doi = "10.1002/ptr.3286",
language = "English (US)",
volume = "25",
pages = "424--428",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Morelloflavone from Garcinia dulcis as a novel biflavonoid inhibitor of HMG-CoA reductase

AU - Tuansulong, Ku Aida

AU - Hutadilok-Towatana, Nongporn

AU - Mahabusarakam, Wilawan

AU - Pinkaew, Decha

AU - Fujise, Kenichi

PY - 2011/3

Y1 - 2011/3

N2 - Morelloflavone, a biflavonoid from Garcinia dulcis previously shown to have hypocholesterolemic activity, was examined for its effect on HMG-CoA reductase, the rate-limiting enzyme of the cholesterol biosynthetic pathway. By using the catalytic domain of house mouse HMG-CoA reductase, morelloflavone was found to inhibit the enzyme activity by competing with HMG-CoA whereas it was non-competitive towards NADPH. The inhibition constants (Ki) with respect to HMG-CoA and NADPH were 80.87 ± 0.06 μM and 103 ± 0.07 μM, respectively. Both flavonoid subunits of this compound, naringenin and luteolin, equally competed with HMGCoA with Ki of 83.58 ± 4.37 mM and 83.59 ± 0.94 μM, respectively, and were also non-competitive with NADPH (Ki of 182 ± 0.67 μM and 188 ± 0.14 μM, respectively). Due to these findings, we suggest that each subunit of morelloflavone would occupy the active site of the enzyme, thereby blocking access of its substrate. The present study thus demonstrates the ability of morelloflavone from G. dulcis to inhibit HMG-CoA reductase in vitro. As a result, this biflavonoid might serve as a new candidate for the future development of hypocholesterolemic agents.

AB - Morelloflavone, a biflavonoid from Garcinia dulcis previously shown to have hypocholesterolemic activity, was examined for its effect on HMG-CoA reductase, the rate-limiting enzyme of the cholesterol biosynthetic pathway. By using the catalytic domain of house mouse HMG-CoA reductase, morelloflavone was found to inhibit the enzyme activity by competing with HMG-CoA whereas it was non-competitive towards NADPH. The inhibition constants (Ki) with respect to HMG-CoA and NADPH were 80.87 ± 0.06 μM and 103 ± 0.07 μM, respectively. Both flavonoid subunits of this compound, naringenin and luteolin, equally competed with HMGCoA with Ki of 83.58 ± 4.37 mM and 83.59 ± 0.94 μM, respectively, and were also non-competitive with NADPH (Ki of 182 ± 0.67 μM and 188 ± 0.14 μM, respectively). Due to these findings, we suggest that each subunit of morelloflavone would occupy the active site of the enzyme, thereby blocking access of its substrate. The present study thus demonstrates the ability of morelloflavone from G. dulcis to inhibit HMG-CoA reductase in vitro. As a result, this biflavonoid might serve as a new candidate for the future development of hypocholesterolemic agents.

KW - Biflavonoid

KW - Cholesterol biosynthesis

KW - Garcinia dulcis

KW - HMG-CoA reductase inhibitor

KW - Morelloflavone

UR - http://www.scopus.com/inward/record.url?scp=79952217473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952217473&partnerID=8YFLogxK

U2 - 10.1002/ptr.3286

DO - 10.1002/ptr.3286

M3 - Article

C2 - 20734327

AN - SCOPUS:79952217473

VL - 25

SP - 424

EP - 428

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 3

ER -